PEDIATRIC ANESTHESIA: Edited by Jorge A. GálvezCongenital heart disease in adults (when kids grow up) pediatric geriatric anesthesiaMotta, Pabloa; Manrique, Ana M.b; Partington, Sara L.c; Ullah, Sanad; Zabala, Luis M.dAuthor Information aArthur S. Keats Division of Pediatric Cardiovascular Anesthesiology, Department of Anesthesiology, Perioperative and Pain Medicine, Texas Children's Hospital, Baylor College of Medicine, Houston, Texas bDivision of Cardiothoracic Anesthesiology, Children's Hospital of Philadelphia cPhiladelphia Adult Congenital Heart Center, a joint program of the Hospital of the University of Pennsylvania and the Children's Hospital of Philadelphia dDepartment of Anesthesiology and Pain Management, UT Southwestern Medical Center, Children's Health, Dallas, Texas, USA Correspondence to Pablo Motta, Associate Professor of Anesthesiology, Arthur S. Keats Division of Pediatric Cardiovascular Anesthesiology, Department of Anesthesiology, Perioperative and Pain Medicine, Texas Children's Hospital, Baylor College of Medicine, 6651 Main Street, Mail Code E.1940.24, Houston, TX 77030, USA. Tel: +1 832 826 1718; fax: +1 832 825 5804; e-mail: email@example.com Supplemental digital content is available for this article. Direct URL citations appear in the printed text and are provided in the HTML and PDF versions of this article on the journal's Website (www.co-anesthesiology.com). Current Opinion in Anaesthesiology: June 2020 - Volume 33 - Issue 3 - p 335-342 doi: 10.1097/ACO.0000000000000849 Buy SDC Metrics Abstract Purpose of review The current review focuses on the new development of adult congenital heart disease (ACHD) patients in the areas of imaging, percutaneous interventions, ventricular assist devices and transplantation. Recent findings Since the last ACHD publication in the journal, several advances have been made in the evaluation and treatment of these patients. As CHD patients’ longevity increases pregnancy, comorbities and acquired heart disease become a concern. Recent data show that the incidence of complications in low-risk CHD is not higher that the regular population. In addition, breakthrough research in percutaneous valve implantation has been published showing good outcomes but needing intensive care recovery in a significant number of patients. In the ACHD heart failure population, assist device and transplant fields mounting evidence shows that these therapies should not be the last resort since low-risk ACHD patient may have similar outcomes to those with acquired heart disease. Finally risk stratification is important in ACHD to define better ways to recover from surgery and anesthesia. Summary The field of anesthesia for ACHD is growing with new indications for diagnostic, interventional and surgical procedures. Tailoring cardiac and noncardiac care to the different risk profile in ACHD patients will be defined in the next few years. Motta summary clip: http://links.lww.com/COAN/A65. Copyright © 2020 YEAR Wolters Kluwer Health, Inc. All rights reserved.